BAIRD'S PHARMACY LIMITED

SC438418
Active Aberdeen

Other business support service activities n.e.c.

129 employees website.com
Healthcare and wellbeing Other business support service activities n.e.c.
B

BAIRD'S PHARMACY LIMITED

SC438418

Other business support service activities n.e.c.

Founded 7 Dec 2012 Active Aberdeen, United Kingdom 129 employees website.com
Healthcare and wellbeing Other business support service activities n.e.c.
Accounts Submitted 30 Jan 2026 Next due 31 Oct 2026 4 months remaining
Confirmation Submitted 22 Jan 2026 Next due 23 Dec 2026 6 months remaining
Net assets £1M £2M 2024 year on year
Total assets £9M £290K 2024 year on year
Total Liabilities £7M £2M 2024 year on year
Charges 10
3 outstanding 7 satisfied

Contact & Details

Contact

Registered Address

302-308 Clifton Road Aberdeen Aberdeenshire AB24 4HP United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for BAIRD'S PHARMACY LIMITED (SC438418), an active healthcare and wellbeing company based in Aberdeen, United Kingdom. Incorporated 7 Dec 2012. Other business support service activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Feb → 31 Jan 2025
Type group
Next accounts 31 Jan 2026
Due by 31 Oct 2026 4 months remaining

Balance Sheet & P&L (2013–2024)

Cash in Bank

£455.78k

Increased by £455.63k (+309952%)

Net Assets

£1.41M

Decreased by £1.51M (-52%)

Total Liabilities

£7.21M

Increased by £1.80M (+33%)

Turnover

£12.64M

Employees

129

Increased by 56 (+77%)

Debt Ratio

84%

Increased by 19 (+29%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Jan Year End
2024
30 Jan Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Grants 1

Investors (0)

No investor information available

Officers

Officers

3 active
Status
Michelle BairdDirectorBritishScotland467 Dec 2012Active
Myrtle BairdDirectorBritishScotland737 Dec 2012Active
Robert Mackie BairdDirectorBritishScotland757 Dec 2012Active

Shareholders

Shareholders (5)

Nicol Robert Baird
65.8%
Robert Mackie Baird
12.7%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased

Nicol Robert Baird

British

Active
Notified 6 Apr 2016
Residence Scotland
DOB September 1978
Nature of Control
  • Ownership Of Shares 50 To 75 Percent,voting Rights 50 To 75 Percent,right To Appoint And Remove Directors

Michelle Baird

Ceased 8 Dec 2023

Ceased

Santander Uk Plc

Ceased 9 Sept 2021

Ceased

Group Structure

Group Structure

BAIRD'S PHARMACY LIMITED Current Company

Charges

Charges

3 outstanding 7 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
30 Jan 2026AccountsAnnual accounts made up to 31 Jan 2025
22 Jan 2026OfficersChange to director Mrs Michelle Baird on 5 Dec 2025
22 Jan 2026Confirmation StatementConfirmation statement made on 9 Dec 2025 with no updates
17 Nov 2025CapitalCapital Cancellation Shares
17 Nov 2025CapitalCapital Return Purchase Own Shares
30 Jan 2026 Accounts

Annual accounts made up to 31 Jan 2025

22 Jan 2026 Officers

Change to director Mrs Michelle Baird on 5 Dec 2025

22 Jan 2026 Confirmation Statement

Confirmation statement made on 9 Dec 2025 with no updates

17 Nov 2025 Capital

Capital Cancellation Shares

17 Nov 2025 Capital

Capital Return Purchase Own Shares

Recent Activity

Latest Activity

Annual accounts made up to 31 Jan 2025

4 months ago on 30 Jan 2026

Change to director Mrs Michelle Baird on 5 Dec 2025

4 months ago on 22 Jan 2026

Confirmation statement made on 9 Dec 2025 with no updates

4 months ago on 22 Jan 2026

Capital Cancellation Shares

7 months ago on 17 Nov 2025

Capital Return Purchase Own Shares

7 months ago on 17 Nov 2025